Viewing StudyNCT06482112



Ignite Creation Date: 2024-07-17 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06482112
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-01
First Post: 2024-06-26

Brief Title: Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD MK-6024-016
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-08-01
Start Date Type: ESTIMATED
Primary Completion Date: 2025-10-16
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-10-16
Completion Date Type: ESTIMATED
First Submit Date: 2024-06-26
First Submit QC Date: None
Study First Post Date: 2024-07-01
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-09
Last Update Post Date: 2024-07-01
Last Update Post Date Type: ACTUAL